Individualized Homeopathic Medicines versus Standard Care in the Treatment of Scabies in Children: A Prospective, Longitudinal Study of Two Parallel Cohorts
Journal of Clinical Infectious Disease Society · 2026-04 · 4 (2) · 145-152
DOI: 10.4103/cids.cids_47_25 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Clinical Infectious Disease Society, online erschienen am 18.06.2026. Verfasst von Animesh Maity und 11 weiteren Autor:innen. Die Arbeit nennt 11 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).
Themen: Kinderkrankenpflege
Abstract (Originalsprache)
Background
Scabies, a parasitic skin infestation caused by Sarcoptes scabiei var hominis , is a global public health concern, particularly in resource-limited settings where resistance to standard therapies such as permethrin is rising, and recurrence rates remain high.
Objective
This study aimed to compare the effectiveness and safety of individualized homeopathic medicines (IHMs) with standard permethrin ointment in treating pediatric scabies and to evaluate the impacts on quality of life.
Methods
A longitudinal, prospective study with two parallel cohorts was conducted in Kolkata across homeopathic and conventional dermatology clinics. Children aged 5–18 years diagnosed with scabies received either IHMs or 5% permethrin cream. Each group included 50 participants. “Clinical cure,” days to recovery, improvements in Skindex-29, Dermatological Quality of Life (DLQI), and Children’s DLQI scores, and adverse events (AEs) were assessed systematically over 2 months.
Results
Of 110 screened, 100 children were enrolled and analyzed (50 per group). Clinical cure rates were similar (IHMs: 90% and permethrin: 88%; P = 1.00). Median times to recovery were both 14 days ( P = 0.316). The IHM group showed a greater reduction and consistency in quality-of-life scores. No AEs occurred with IHMs; five cases of minor local reactions were reported for permethrin.
Conclusion
IHMs provided clinical cure, recovery times, and superior quality-of-life improvements comparable to permethrin, with an excellent safety profile. The findings support the use of IHMs as a safe, effective, patient-centered alternative or adjunct in integrated scabies management, especially where conventional treatment access or efficacy is limited.
Trial registration
CTRI/2023/04/051248; UTN: U1111-1289-9581.
Zitieren
APA
Maity, A., Hossain, M. S., Bhar, C., Basu, A., Shamim, S., Bhattacharyya, S., Debnath, P., Jain, H., Yaduvanshi, S., Parveen, T., Koley, M., & Saha, S. (2026). Individualized Homeopathic Medicines versus Standard Care in the Treatment of Scabies in Children: A Prospective, Longitudinal Study of Two Parallel Cohorts. Journal of Clinical Infectious Disease Society, 4(2), 145-152. https://doi.org/10.4103/cids.cids_47_25
Vancouver
Maity A, Hossain MS, Bhar C, Basu A, Shamim S, Bhattacharyya S, et al. Individualized Homeopathic Medicines versus Standard Care in the Treatment of Scabies in Children: A Prospective, Longitudinal Study of Two Parallel Cohorts. Journal of Clinical Infectious Disease Society. 2026;4(2):145-152. doi:10.4103/cids.cids_47_25
BibTeX
@article{Maity2026,
author = {Maity, Animesh and Hossain, Md. Sakhawat and Bhar, Chanchal and Basu, Arpita and Shamim, Saima and Bhattacharyya, Soumya and Debnath, Pintu and Jain, Himani and Yaduvanshi, Surbhi and Parveen, Tuhina and Koley, Munmun and Saha, Subhranil},
title = {Individualized Homeopathic Medicines versus Standard Care in the Treatment of Scabies in Children: A Prospective, Longitudinal Study of Two Parallel Cohorts},
journal = {Journal of Clinical Infectious Disease Society},
year = {2026},
volume = {4},
number = {2},
pages = {145--152},
doi = {10.4103/cids.cids_47_25}
}
EUVIMED